Brodalumab (Siliq) with a fatal touch: New psoriasis drug approved
February 16, 2017 – The American Food & Drug Administration (FDA) just approved Brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab (Siliq) is administered as an injection. Brodalumab (Siliq) is intended for patients who are candidates for systemic therapy (treatment …
Brodalumab (Siliq) with a fatal touch: New psoriasis drug approved Read more »